Heterogeneous ribonucleoprotein K and thymidine phosphorylase are independent prognostic and therapeutic markers for oral squamous cell carcinoma

Oral Oncology

Volumn 48, Issue 6, 2012, Pages 516-522

  Wu, Chi Sheng ^a   Chang, Kai Ping ^b   Chen, Lih Chyang ^a   Chen, Chia Chun ^a   Liang, Ying ^a   Hseuh, Chuen ^a,b   Chang, Yu Sun ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

FLIP; hnRNP K; Oral squamous cell carcinoma; Therapeutic marker; TP

Indexed keywords

FLICE INHIBITORY PROTEIN; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN K; THYMIDINE PHOSPHORYLASE;

ADULT; ARTICLE; CANCER SURVIVAL; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; DRUG SENSITIVITY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MOUTH SQUAMOUS CELL CARCINOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SURVIVAL PREDICTION; TREATMENT OUTCOME; UPREGULATION;

ANTIMETABOLITES, ANTINEOPLASTIC; CARCINOMA, SQUAMOUS CELL; CASP8 AND FADD-LIKE APOPTOSIS REGULATING PROTEIN; FEMALE; FLOXURIDINE; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEIN K; HUMANS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; PROGNOSIS; RETROSPECTIVE STUDIES; THYMIDINE PHOSPHORYLASE;

EID: 84862800183     PISSN: 13688375     EISSN: 18790593     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2012.01.005     Document Type: Article

References (19)

1. D.M. Parkin, F. Bray, J. Ferlay, and P. Pisani Global cancer statistics, 2002 CA Cancer J Clin 55 2 2005 74 108
2. B.C. Reid, D.M. Winn, D.E. Morse, and D.G. Pendrys Head and neck in situ carcinoma: incidence, trends, and survival Oral Oncol 36 5 2000 414 420
3. L.C. Chen, C. Hsueh, N.M. Tsang, Y. Liang, K.P. Chang, and S.P. Hao Heterogeneous ribonucleoprotein k and thymidine phosphorylase are independent prognostic and therapeutic markers for nasopharyngeal carcinoma Clin Cancer Res 14 12 2008 3807 3813
4. L.C. Chen, H.P. Liu, H.P. Li, C. Hsueh, J.S. Yu, and C.L. Liang Thymidine phosphorylase mRNA stability and protein levels are increased through ERK-mediated cytoplasmic accumulation of hnRNP K in nasopharyngeal carcinoma cells Oncogene 28 17 2009 1904 1915
5. K. Bomsztyk, O. Denisenko, and J. Ostrowski hnRNP K: one protein multiple processes Bioessays 26 6 2004 629 638
6. M. Notari, P. Neviani, R. Santhanam, B.W. Blaser, J.S. Chang, and A. Galietta A MAPK/HNRPK pathway controls BCR/ABL oncogenic potential by regulating MYC mRNA translation Blood 107 6 2006 2507 2516
7. M. Lynch, L. Chen, M.J. Ravitz, S. Mehtani, K. Korenblat, and M.J. Pazin hnRNP K binds a core polypyrimidine element in the eukaryotic translation initiation factor 4E (eIF4E) promoter, and its regulation of eIF4E contributes to neoplastic transformation Mol Cell Biol 25 15 2005 6436 6453
8. A. Inoue, S.Y. Sawata, K. Taira, and R. Wadhwa Loss-of-function screening by randomized intracellular antibodies: identification of hnRNP-K as a potential target for metastasis Proc Natl Acad Sci USA 104 21 2007 8983 8988
9. F. Ishikawa, K. Miyazono, U. Hellman, H. Drexler, C. Wernstedt, and K. Hagiwara Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor Nature 338 6216 1989 557 562
10. H. Tsuzuki, H. Sunaga, T. Ito, N. Narita, C. Sugimoto, and S. Fujieda Reliability of platelet-derived endothelial cell growth factor as a prognostic factor for oral and oropharyngeal carcinomas Arch Otolaryngol Head Neck Surg 131 12 2005 1071 1078
11. J.K. Yang FLIP as an anti-cancer therapeutic target Yonsei Med J 49 1 2008 19 27
12. L.C. Chen, I.C. Chung, C. Hsueh, N.M. Tsang, L.M. Chi, and Y. Liang The antiapoptotic protein, FLIP, is regulated by heterogeneous nuclear ribonucleoprotein K and correlates with poor overall survival of nasopharyngeal carcinoma patients Cell Death Differ 17 9 2010 1463 1473
13. A. Elnemr, T. Ohta, A. Yachie, M. Kayahara, H. Kitagawa, and T. Fujimura Human pancreatic cancer cells disable function of Fas receptors at several levels in Fas signal transduction pathway Int J Oncol 18 2 2001 311 316
14. S.Y. Nam, G.A. Jung, G.C. Hur, H.Y. Chung, W.H. Kim, and D.W. Seol Upregulation of FLIP(S) by Akt, a possible inhibition mechanism of TRAIL-induced apoptosis in human gastric cancers Cancer Sci 94 12 2003 1066 1073
15. A. Matta, S.C. Tripathi, L.V. DeSouza, J. Grigull, J. Kaur, and S.S. Chauhan Heterogeneous ribonucleoprotein K is a marker of oral leukoplakia and correlates with poor prognosis of squamous cell carcinoma Int J Cancer 125 6 2009 1398 1406
16. K.H. Fang, H.K. Kao, M.H. Cheng, Y.L. Chang, N.M. Tsang, and Y.C. Huang Histological differentiation of primary oral squamous cell carcinomas in an area of betel quid chewing prevalence Otolaryngol Head Neck Surg 141 6 2009 743 749
17. K.P. Chang, H.K. Kao, T.C. Yen, Y.L. Chang, Y. Liang, and S.C. Liu Overexpression of macrophage inflammatory protein-3alpha in oral cavity squamous cell carcinoma is associated with nodal metastasis Oral Oncol 47 2 2011 108 113
18. H. Ishitsuka Capecitabine: preclinical pharmacology studies Invest New Drugs 18 4 2000 343 354
19. M. de Bruin, T. van Capel, K. Van der Born, F.A. Kruyt, M. Fukushima, and K. Hoekman Role of platelet-derived endothelial cell growth factor/thymidine phosphorylase in fluoropyrimidine sensitivity Br J Cancer 88 6 2003 957 964